Differential gene expression profile may differentiate responders from non-reponders rheumatoid arthritis patients to methotrexate monotherapy and methotrexate plus TNF-blocker combined therapy
Ontology highlight
ABSTRACT: Oligo microarrays were used to access the transcription profiling of the rheumatoid arthritis patients under two different therapeutic approaches, aiming to evaluate if the cDNA microarray study is able to differentiate responders and non-responders to therapies. In the first experiment (MTX therapy) we analyzed 25 patients from which 8 were classified as MTX responders and 17 MTX non-responders. In the second experiment from the 17 MTX non-responder patients, 8 were non-responders and 9 were responders to additional anti-TNF therapy.
ORGANISM(S): Homo sapiens
SUBMITTER: Geraldo Passos
PROVIDER: E-MEXP-3390 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA